Japan Tobacco, Torii Report Positive Top-Line Results From Phase III Zerenex Study

Japan Tobacco, Keryx Biopharmaceuticals’ Japanese partner, and Torii Pharmaceutical have reported positive top-line results from Phase III study of ferric citrate (Zerenex) in Japan.
Pharmaceutical Business Review